Non-Invasive Prenatal Testing (NIPT) Market Research Report Information By Product Type (Devices, Consumables), Techniques (Biochemical Screening Tests, Ultrasound Detection), Application (Trisomy, Microdeletion syndrome) and End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) - Forecast to 2032

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Devices

6.2.1. Ultrasound Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Polymerase Chain Reaction Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Microarrays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Sequencing Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Consumables

6.3.1. Assay Kits & Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Disposables

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUE

7.1. Overview

7.2. Biochemical Screening Tests

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Ultrasound Detection

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION

8.1. Overview

8.2. Trisomy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Microdeletion Syndrome

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Research institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1.1. Overview

11.1.2. Competitive Analysis

12. COMPANY PROFILES

12.1. Illumina, Inc.

12.1.1. Company Overview

12.1.2. Product Type Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Thermo Fisher Scientific, Inc.

12.2.1. Company Overview

12.2.2. Product Type Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. General Electric Company (GE Healthcare)

12.3.1. Company Overview

12.3.2. Product Type Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. PerkinElmer Inc.

12.4.1. Company Overview

12.4.2. Product Type Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Agilent Technologies, Inc

12.5.1. Company Overview

12.5.2. Product Type Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Beijing Genomics Institute.

12.6.1. Company Overview

12.6.2. Product Type Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. F. Hoffman-La Roche Ltd.

12.7.1. Company Overview

12.7.2. Product Type Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Natera, Inc.

12.8.1. Company Overview

12.8.2. Product Type Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. YOURGENE HEALTH

12.9.1. Company Overview

12.9.2. Product Type Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Centogene Holding AG (CENTOGENE AG)

12.10.1. Company Overview

12.10.2. Product Type Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ESTIMATES & FORECAST, 2020-2027(USD MILLION)

TABLE 3 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(USD MILLION)

TABLE 4 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 5 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 6 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 7 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION, 2020-2027(USD MILLION)

TABLE 8 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(USD MILLION)

TABLE 9 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 10 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 11 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 12 US: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(USD MILLION)

TABLE 13 US: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 14 US: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 15 US: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 16 CANADA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 17 CANADA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 18 CANADA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 19 CANADA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 20 LATIN AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 21 LATIN AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 22 LATIN AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 23 LATIN AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 24 EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 25 EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 26 EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 27 EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 28 WESTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 29 WESTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 30 WESTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 31 WESTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 32 EASTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 33 EASTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 34 EASTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 35 EASTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 36 ASIA-PACIFIC: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 37 ASIA-PACIFIC: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 38 ASIA-PACIFIC: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 39 ASIA-PACIFIC: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY PRODUCT TYPE, 2020-2027(US MILLION)

TABLE 41 MIDDLE EAST & AFRICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNIQUES, 2020-2027(USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2020-2027(USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2020-2027(USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET

FIGURE 4 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 5 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY TECHNIQUES, 2020 (%)

FIGURE 6 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ILLUMINA, INC..: KEY FINANCIALS

FIGURE 16 ILLUMINA, INC.: SEGMENTAL REVENUE

FIGURE 17 ILLUMINA, INC.: REGIONAL REVENUE

FIGURE 18 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS

FIGURE 19 THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE

FIGURE 20 THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE

FIGURE 21 GENERAL ELECTRIC COMPANY: KEY FINANCIALS

FIGURE 22 GENERAL ELECTRIC COMPANY: SEGMENTAL REVENUE

FIGURE 23 GENERAL ELECTRIC COMPANY: REGIONAL REVENUE

FIGURE 24 PERKINELMER INC.: KEY FINANCIALS

FIGURE 25 PERKINELMER INC.: SEGMENTAL REVENUE

FIGURE 26 PERKINELMER INC.: REGIONAL REVENUE

FIGURE 27 AGILENT TECHNOLOGIES, INC: KEY FINANCIALS

FIGURE 28 AGILENT TECHNOLOGIES, INC: SEGMENTAL REVENUE

FIGURE 29 AGILENT TECHNOLOGIES, INC: REGIONAL REVENUE

FIGURE 30 BEIJING GENOMICS INSTITUTE: KEY FINANCIALS

FIGURE 31 BEIJING GENOMICS INSTITUTE: SEGMENTAL REVENUE

FIGURE 32 BEIJING GENOMICS INSTITUTE: REGIONAL REVENUE

FIGURE 33 F. HOFFMAN-LA ROCHE LTD.: KEY FINANCIALS

FIGURE 34 F. HOFFMAN-LA ROCHE LTD.: SEGMENTAL REVENUE

FIGURE 35 F. HOFFMAN-LA ROCHE LTD.: REGIONAL REVENUE

FIGURE 36 NATERA, INC.: KEY FINANCIALS

FIGURE 37 NATERA, INC.: SEGMENTAL REVENUE

FIGURE 38 NATERA, INC.: REGIONAL REVENUE

FIGURE 39 YOURGENE HEALTH: KEY FINANCIALS

FIGURE 40 YOURGENE HEALTH: SEGMENTAL REVENUE

FIGURE 41 YOURGENE HEALTH: REGIONAL REVENUE

FIGURE 42 CENTOGENE HOLDING AG: KEY FINANCIALS

FIGURE 43 CENTOGENE HOLDING AG: SEGMENTAL REVENUE

FIGURE 44 CENTOGENE HOLDING AG: REGIONAL REVENUE